Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medical device company Lumenis has announced plans to align their ophthalmic strategic business unit, Lumenis Vision, for aggressive growth while at the same time ensuring standards of quality and reliability.
Subscribe to our email newsletter
Lumenis ophthalmic unit has been streamlined to report to Gideon Sturlesi, who will lead the unit for the present time in addition to his role as Lumenis’s corporate vice president for business development. He will replace Jake Zanden, senior vice president and general manager of Lumenis ophthalmic strategic business unit who is leaving the company.
Mr Sturlesi is a seasoned executive with experience in heading successful turnarounds with proven hands on management experience. Prior to joining Lumenis, Mr Sturlesi served as co-founder of Galil Medical and as CEO of its US activity, and was the founder and general partner of BioMedical Israel.
Mr Sturlesi holds a BSc and MSc (cum-laude) from the Technion – Israel Institute of Technology and holds patents and has released publications in medical device technology.